Literature DB >> 15743806

Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Jaya Rajaiya1, Melissa Hatfield, Jamee C Nixon, David J Rawlings, Carol F Webb.   

Abstract

Bright (B-cell regulator of immunoglobulin heavy chain transcription) binding to immunoglobulin heavy chain loci after B-cell activation is associated with increased heavy chain transcription. Our earlier reports demonstrated that Bright coimmunoprecipitates with Bruton's tyrosine kinase (Btk) and that these proteins associate in a DNA-binding complex in primary B cells. B cells from immunodeficient mice with a mutation in Btk failed to produce stable Bright DNA-binding complexes. In order to determine if Btk is important for Bright function, a transcription activation assay was established and analyzed using real-time PCR technology. Cells lacking both Bright and Btk were transfected with Bright and/or Btk along with an immunoglobulin heavy chain reporter construct. Immunoglobulin gene transcription was enhanced when Bright and Btk were coexpressed. In contrast, neither Bright nor Btk alone led to activation of heavy chain transcription. Furthermore, Bright function required both Btk kinase activity and sequences within the pleckstrin homology domain of Btk. Bright was not appreciably phosphorylated by Btk; however, a third tyrosine-phosphorylated protein coprecipitated with Bright. Thus, the ability of Bright to enhance immunoglobulin transcription critically requires functional Btk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743806      PMCID: PMC1061591          DOI: 10.1128/MCB.25.6.2073-2084.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Identification of a matrix-associated region 5' of an immunoglobulin heavy chain variable region gene.

Authors:  C F Webb; C Das; K L Eneff; P W Tucker
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

2.  Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement.

Authors:  S J Saouaf; S Mahajan; R B Rowley; S A Kut; J Fargnoli; A L Burkhardt; S Tsukada; O N Witte; J B Bolen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

3.  Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells.

Authors:  Y Aoki; K J Isselbacher; B J Cherayil; S Pillai
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

4.  Constitutive membrane association potentiates activation of Bruton tyrosine kinase.

Authors:  T Li; D J Rawlings; H Park; R M Kato; O N Witte; A B Satterthwaite
Journal:  Oncogene       Date:  1997-09-18       Impact factor: 9.867

5.  A topoisomerase II-like protein is part of an inducible DNA-binding protein complex that binds 5' of an immunoglobulin promoter.

Authors:  C F Webb; K L Eneff; F H Drake
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

6.  B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.

Authors:  M de Weers; G S Brouns; S Hinshelwood; C Kinnon; R K Schuurman; R W Hendriks; J Borst
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

7.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.

Authors:  D J Rawlings; D C Saffran; S Tsukada; D A Largaespada; J C Grimaldi; L Cohen; R N Mohr; J F Bazan; M Howard; N G Copeland
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

8.  Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.

Authors:  J D Thomas; P Sideras; C I Smith; I Vorechovský; V Chapman; W E Paul
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

9.  Induction of immunoglobulin mu mRNA in a B cell transfectant stimulated with interleukin-5 and a T-dependent antigen.

Authors:  C F Webb; C Das; R L Coffman; P W Tucker
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

10.  The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C.

Authors:  L Yao; Y Kawakami; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more
  23 in total

1.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

2.  The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.

Authors:  Carol F Webb; James Bryant; Melissa Popowski; Laura Allred; Dongkoon Kim; June Harriss; Christian Schmidt; Cathrine A Miner; Kira Rose; Hwei-Ling Cheng; Courtney Griffin; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

3.  Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.

Authors:  Josephine A Tidwell; Christian Schmidt; Phillip Heaton; Van Wilson; Philip W Tucker
Journal:  Mol Immunol       Date:  2011-09-28       Impact factor: 4.407

4.  Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Authors:  Christian Schmidt; Dongkyoon Kim; Gregory C Ippolito; Hassan R Naqvi; Loren Probst; Shawn Mathur; German Rosas-Acosta; Van G Wilson; Athenia L Oldham; Martin Poenie; Carol F Webb; Philip W Tucker
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

5.  Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.

Authors:  Jaya Rajaiya; Jamee C Nixon; Neil Ayers; Zana P Desgranges; Ananda L Roy; Carol F Webb
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 6.  BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.

Authors:  M Spaargaren; M F M de Rooij; A P Kater; E Eldering
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

7.  Loss of Bright/ARID3a function promotes developmental plasticity.

Authors:  Guangyu An; Cathrine A Miner; Jamee C Nixon; Paul W Kincade; James Bryant; Philip W Tucker; Carol F Webb
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

8.  A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes.

Authors:  Dongkyoon Kim; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

9.  Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Authors:  Jamee C Nixon; Scott Ferrell; Cathrine Miner; Athenia L Oldham; Ute Hochgeschwender; Carol F Webb
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 10.  Perspectives on fetal derived CD5+ B1 B cells.

Authors:  Richard R Hardy; Kyoko Hayakawa
Journal:  Eur J Immunol       Date:  2015-09-23       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.